MedPath

Efficacy of Gamma - tACS on Cognition and Craving in Alcohol Use Disorder

Not Applicable
Conditions
Health Condition 1: F102- Alcohol dependence
Registration Number
CTRI/2023/10/058609
Lead Sponsor
Central Institute of Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Male patients diagnosed with Alcohol Dependence Syndrome as per International Classification of Disease - 11th revision - Diagnostic Criteria for Research (WHO, 2022).

2. Male with Alcohol Dependence aged between 18 to 60 years.

3. Severity of Alcohol Dependence Questionnaire (SADQ) in Male with Alcohol dependence greater than 16

4. The Clinical Institute Withdrawal Assessment for Alcohol (revised version) in Male with Alcohol dependence CIWA-Ar lesser than 10.

5. Right-handed

6. Male with Alcohol dependence who give informed consent.

7. Patients will be screened for cognitive deficit with Montreal Cognitive Assessment Test (MoCA). Cut off score is =25.

Exclusion Criteria

1. Male with Alcohol dependence having any other co-morbid substance dependence except nicotine and caffeine.

2. Male with Alcohol dependence having any medical illness.

3. Male with Alcohol dependence having any other psychiatric illness, dementia, psychotic disorder,

4. Male with Alcohol dependence who are on any psychotropic medication or any anticraving medication in 2 weeks preceding and during the study.

5. Clinically diagnosed intellectual disability.

6. Past history of significant head injury.

7. Past history of epilepsy(Patients with history of alcohol withdrawal seizure will be included).

8. HAMD Score = 8.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath